| Blocking immunoinhibitory receptor LILRB2 reprograms tumor-associated myeloid cells and promotes antitumor immunity HM Chen, W van der Touw, YS Wang, K Kang, S Mai, J Zhang, ... The Journal of clinical investigation 128 (12), 5647-5662, 2018 | 180 | 2018 |
| ST2 blockade reduces sST2-producing T cells while maintaining protective mST2-expressing T cells during graft-versus-host disease J Zhang, AM Ramadan, B Griesenauer, W Li, MJ Turner, C Liu, R Kapur, ... Science translational medicine 7 (308), 308ra160-308ra160, 2015 | 165 | 2015 |
| Proteomics analysis reveals a Th17-prone cell population in presymptomatic graft-versus-host disease W Li, L Liu, A Gomez, J Zhang, A Ramadan, Q Zhang, SW Choi, P Zhang, ... JCI insight 1 (6), 2016 | 50 | 2016 |
| The mechanistic study behind suppression of GVHD while retaining GVL activities by myeloid-derived suppressor cells J Zhang, HM Chen, G Ma, Z Zhou, D Raulet, AL Rivera, SH Chen, PY Pan Leukemia, 2019 | 48 | 2019 |
| Leukocyte immunoglobulin-like receptors in human diseases: an overview of their distribution, function, and potential application for immunotherapies J Zhang, S Mai, HM Chen, K Kang, XC Li, SH Chen, PY Pan Journal of leukocyte biology 102 (2), 351-360, 2017 | 47 | 2017 |
| CD3 mAb treatment ameliorated the severity of the cGVHD-induced lupus nephritis in mice by up-regulation of Foxp3+ regulatory T cells in the target tissue: kidney. J Zhang, H Xiao Transplant Immunology 24 (1), 17-25, 2010 | 34 | 2010 |
| From proteomics to discovery of first-in-class ST2 inhibitors active in vivo AM Ramadan, E Daguindau, JC Rech, K Chinnaswamy, J Zhang, ... JCI insight 3 (14), 2018 | 33 | 2018 |
| Rorc restrains the potency of ST2+ regulatory T cells in ameliorating intestinal graft-versus-host disease J Yang, A Ramadan, DK Reichenbach, M Loschi, J Zhang, B Griesenauer, ... JCI insight 4 (5), 2019 | 22 | 2019 |
| Mouse pulmonary interstitial macrophages mediate the pro-tumorigenic effects of IL-9 Y Fu, A Pajulas, J Wang, B Zhou, A Cannon, CCL Cheung, J Zhang, ... Nature communications 13 (1), 3811, 2022 | 21 | 2022 |
| Myeloid-Derived Suppressor Cells as Cellular Immunotherapy In Transplantation and Autoimmune diseases J Zhang, A Hodges, SH Chen, PY Pan Cellular Immunology 362, 2021 | 21 | 2021 |
| ST2/MyD88 deficiency protects mice against acute graft-versus-host disease and spares regulatory T cells B Griesenauer, H Jiang, J Yang, J Zhang, AM Ramadan, J Egbosiuba, ... The Journal of Immunology 202 (10), 3053-3064, 2019 | 16 | 2019 |
| Virus‐mimic mRNA vaccine for cancer treatment C Meng, Z Chen, J Mai, Q Shi, S Tian, L Hinkle, J Li, Z Zhang, M Ramirez, ... Advanced Therapeutics 4 (11), 2100144, 2021 | 15 | 2021 |
| Interleukin-9 promotes mast cell progenitor proliferation and CCR2-dependent mast cell migration in allergic airway inflammation A Pajulas, Y Fu, CCL Cheung, M Chu, A Cannon, N Alakhras, J Zhang, ... Mucosal immunology 16 (4), 432-445, 2023 | 8 | 2023 |
| Patients with lung cancer of different racial backgrounds harbor distinct immune cell profiles Y Xu, L Zhang, J Thaiparambil, S Mai, DN Perera, J Zhang, PY Pan, ... Cancer Research Communications 2 (8), 884-893, 2022 | 7 | 2022 |
| The World according to IL-9 A Pajulas, J Zhang, MH Kaplan The Journal of Immunology 211 (1), 7-14, 2023 | 6 | 2023 |
| The dichotomy of interleukin-9 function in the tumor microenvironment A Cannon, A Pajulas, MH Kaplan, J Zhang Journal of Interferon & Cytokine Research 43 (6), 229-245, 2023 | 4 | 2023 |
| LILRB3 modulates acute myeloid leukemia progression and acts as an effective target for CAR T-cell therapy S Mai, A Hodges, HM Chen, J Zhang, YL Wang, Y Liu, F Nakatsu, X Wang, ... Cancer research 83 (24), 4047-4062, 2023 | 3 | 2023 |
| Small Molecule ST2 Inhibitors Cause Reduction of Soluble ST2 and Improve Gvhd and Survival In Vivo CY Yang, A Ramadan, E Daguindau, J Zhang, Z Bolten, K Chinnaswamy, ... Blood 128 (22), 528, 2016 | 3 | 2016 |
| IL-33/ST2 activation of IL-9-secreting T cells alters the balance of fatal immunity and tumor immunity (TRAN1P. 926) A Ramadan, J Zhang, B Griesenauer, R Kapur, H Hanenberg, J Sun, ... The Journal of Immunology 194 (1_Supplement), 140.8-140.8, 2015 | 3 | 2015 |
| A novel Th17-Prone CD146+ CCR5+ T-Cell population as an early marker of intestinal graft-versus-host disease W Li, L Liu, A Gomez, Q Zhang, J Zhang, A Ramadan, CL Mumaw, ... Blood 124 (21), 3, 2014 | 3 | 2014 |
